在接受冠状动脉血管造影的患者中,循环单细胞减少胆固醇晶体的吸收
Nikola Lübbering1, Alexander Krogmann1, Felix Jansen1
1Medizinische Klinik und Poliklinik II, Herzzentrum, Universitätsklinikum Bonn, Bonn, Germany.
PloS one
|December 15, 2025
概括
循环德克斯 (CD) 前期治疗显著降低了人体单细胞中胆固醇晶体 (CC) 的吸收,这表明了动脉样硬化的一种新的治疗方法. 然而,患者对CD的反应有所不同,特别是在具有较高系统性炎症或冠状动脉疾病 (CAD) 的患者中.
科学领域:
- 心血管研究研究心血管研究
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 动脉样硬化是一种慢性炎症性疾病,涉及内皮功能障碍,胆固醇积累和免疫细胞激活.
- 胆固醇晶体 (CC) 通过激活单细胞中的NLRP3炎症体来促进动脉样硬化.
- 在临床前模型中,环氧素 (CD) 已通过增强胆固醇代谢和减少炎症来证明其动脉保护作用.
研究的目的:
- 研究CD预处理对人类单细胞中CC吸收的影响.
- 探索患者特异性因素对CD在调节CC摄取中的疗效的影响.
主要方法:
- 人类外围单核细胞从76名接受冠状动脉血管造影的患者中分离出来.
- 细胞被激发了2-Hydroxypropyl-γ-Cyclodextrin (CD) 和胆固醇晶体 (CC).
- 单细胞的CC摄取量使用流细胞计量量化.
主要成果:
- 单细胞的CC吸收在患者之间有显著差异 (8-37%),在白细胞升高和糖尿病患者中较低.
- 癌症前期治疗显著降低了CC吸收 (从20.1%降至15.0%,p < 0.0001).
- 患者对冠状动脉疾病的反应有所不同;患有冠状动脉疾病 (CAD),白细胞数量较高或需要皮肤冠状动脉干预 (PCI) 的患者显示CC-uptake的减少不那么明显,这表明在系统性炎症升高时CD疗效减弱.
结论:
- CD显著抑制人体单细胞的CC-细胞形成,支持其潜在的动脉保护作用.
- 个体患者对CD的反应各不相同,全身炎症和CAD影响其疗效.
- 研究结果表明,CD在评估心血管风险和监测基于CD的治疗方法方面具有实用性.
相关概念视频
Atherosclerosis III: Management
293
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
293
Coronary Artery Disease IV: Preventive Measures
572
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
572
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Coronary Artery Disease V: Interprofessional Care
203
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
203
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
1.2K
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
1.2K
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
370
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
370


